Asthma
COPD
Pulmonary
COPD: Page 23
FDA clears first over-the-counter fingertip pulse oximeter
Device provides patients with COPD a way to assess blood oxygen levels.
February 28, 2024
Reproductive factors in women linked to heightened COPD risk
Menstruation, miscarriage, infertility and other factors cited in study.
February 19, 2024
Patients with COPD could see improved health from lifestyle changes
Researchers find behavior change interventions lead to health benefits.
February 19, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary rehab for patients with COPD is difficult to access
Study finds millions are more than an hour away from needed care.
February 13, 2024
Cadmium causes deleterious stress in lung cells of patients with COPD
Research points the way to potential therapeutic targets.
February 13, 2024
Novel therapeutic candidate targets COPD
Monoclonal antibody shows promise in early data.
February 2, 2024
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Gum disease can aggravate COPD
Study reveals how periodontitis activates immune cells associated with aggravated progression of COPD.
January 25, 2024
COPD patients may benefit from increased access to palliative care
Study finds one change can dramatically give care to more hospitalized patients.
January 25, 2024
FDA authorizes Florida drug importation program
The program would apply only to certain drugs, including those for asthma and COPD.
January 16, 2024
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
2024 GOLD report emphasizes vaccines for patients with COPD
People with COPD should receive all recommended vaccines.
January 16, 2024
Dupixent (dupilumab) reduced COPD exacerbations in second phase 3 trial
Results could accelerate FDA approval with the potential to become the first approved biologic for COPD.
January 10, 2024
Study for revefenacin inhaler fails to meet goal
Study showed no difference between YUPELRI and Spiriva inhalers.
January 10, 2024
Previous Page
Page 23 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial